CO5261595A1 - Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium - Google Patents

Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium

Info

Publication number
CO5261595A1
CO5261595A1 CO01026726A CO01026726A CO5261595A1 CO 5261595 A1 CO5261595 A1 CO 5261595A1 CO 01026726 A CO01026726 A CO 01026726A CO 01026726 A CO01026726 A CO 01026726A CO 5261595 A1 CO5261595 A1 CO 5261595A1
Authority
CO
Colombia
Prior art keywords
ipratropium
salmeterol
combination
pharmaceutical compositions
compositions containing
Prior art date
Application number
CO01026726A
Other languages
English (en)
Inventor
Ricahrd John Jenkins
David Hugh
Original Assignee
Gloxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gloxo Group Ltd filed Critical Gloxo Group Ltd
Publication of CO5261595A1 publication Critical patent/CO5261595A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica que comprende salmeterol o una sal farmacéuticamente aceptable, solvato, o derivado fisiológicamente funcional del mismo e ipratropium o una sal farmacéuticamente aceptable, solvato, o derivado fisiológicamente funcional del mismo, y un portador o excipiente farmacéuticamente aceptable, y opcionalmente uno o más ingredientes terapéuticos distintos.
CO01026726A 2000-04-07 2001-04-04 Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium CO5261595A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0008485.5A GB0008485D0 (en) 2000-04-07 2000-04-07 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CO5261595A1 true CO5261595A1 (es) 2003-03-31

Family

ID=9889362

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01026726A CO5261595A1 (es) 2000-04-07 2001-04-04 Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium

Country Status (7)

Country Link
US (1) US20030096834A1 (es)
EP (1) EP1272184A2 (es)
JP (1) JP2003530352A (es)
AU (1) AU2001273919A1 (es)
CO (1) CO5261595A1 (es)
GB (1) GB0008485D0 (es)
WO (1) WO2001076601A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20040050960A1 (en) * 2000-12-22 2004-03-18 Godfrey Anne Pauline Metered dose inhaler for salemeterol xinafoate
JP2005539046A (ja) 2002-08-29 2005-12-22 シプラ・リミテッド 特異的な抗コリン作用薬、β−２アゴニスト、および副腎皮質ステロイドを含む、治療薬および組成物
TWI328009B (en) * 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
SE526850C2 (sv) * 2003-06-19 2005-11-08 Microdrug Ag Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
US20050026948A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
EP2327403A3 (en) 2007-02-19 2011-08-31 Cipla Limited Pharmaceutical combinations of at least two bronchodilators
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
HU229064B1 (en) * 1998-06-18 2013-07-29 Boehringer Ingelheim Pharma Pharmaceutical formulations for aerosols with two or more active substances

Also Published As

Publication number Publication date
AU2001273919A1 (en) 2001-10-23
WO2001076601A2 (en) 2001-10-18
US20030096834A1 (en) 2003-05-22
GB0008485D0 (en) 2000-05-24
EP1272184A2 (en) 2003-01-08
JP2003530352A (ja) 2003-10-14
WO2001076601A3 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AP1954A (en) Controlled release compositions comprising nimesulide.
ATE519486T1 (de) Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
CO5261595A1 (es) Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium
HK1080390A1 (en) Pharmaceutical composition for thrombin peptide derivatives
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
AR018197A1 (es) Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento
BR0015188A (pt) Composições farmacêuticas
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
PA8548701A1 (es) Azaindoles
ATE304368T1 (de) Kräuterpflanzen enthaltende artzneimittel
PA8453201A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ME00318B (me) Nova kompozicija i njena upotreba
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
PL356904A1 (en) Pharmaceutical compositions
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
ECSP066878A (es) [hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa
PT1387681E (pt) Compostos antivirais
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
DE602004011966D1 (en) Heterocyclylverbindungen
GB0109122D0 (en) Novel compounds
CO5280222A1 (es) Composicion farmaceutica que comprende pemetrexed
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament